RLMD
Relmada TherapeuticsยทNASDAQ
--
--(--)
--
--(--)
RLMD Profile
Relmada Therapeutics, Inc.
A late-stage biotechnology company that addressing diseases of the central nervous system
2222 Ponce de Leon Blvd., Floor 3, Coral Gables, FL 33134
--
Relmada Therapeutics, Inc., was incorporated under the laws of the State of Nevada. The company is a publicly traded clinical-stage biotechnology company that has shifted its strategic focus following a review of its development programs. It is advancing its R&D pipeline through licensing introductions and acquisitions, including a Phase 2 bladder cancer drug candidate and a neurosteroid for neurological and metabolic diseases ready to enter Phase 2 b.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
